全文获取类型
收费全文 | 90篇 |
免费 | 8篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 3篇 |
妇产科学 | 1篇 |
基础医学 | 13篇 |
口腔科学 | 3篇 |
临床医学 | 19篇 |
内科学 | 17篇 |
皮肤病学 | 1篇 |
神经病学 | 4篇 |
特种医学 | 16篇 |
外科学 | 9篇 |
综合类 | 4篇 |
预防医学 | 5篇 |
药学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 1篇 |
2019年 | 1篇 |
2018年 | 2篇 |
2017年 | 2篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 5篇 |
2010年 | 1篇 |
2009年 | 6篇 |
2008年 | 5篇 |
2007年 | 1篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 5篇 |
2002年 | 3篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1965年 | 1篇 |
1962年 | 1篇 |
1948年 | 1篇 |
排序方式: 共有99条查询结果,搜索用时 16 毫秒
41.
42.
43.
Sperm nitric oxide and motility: the effects of nitric oxide synthase stimulation and inhibition 总被引:2,自引:1,他引:2
Nitric oxide (NO) is synthesized from L-arginine by a family of enzymes
known as the nitric oxide synthases (NOS). We have recently shown a NOS
similar to constitutive brain NOS (bNOS) and endothelial NOS (ecNOS) to be
present in spermatozoa. The aim of this study is to investigate NO
production by human spermatozoa and the effects of stimulation and
inhibition of NOS. This was carried out using the Iso-NO, an isolated NO
meter and sensor, which provides rapid, accurate and direct measurements of
NO. Semen samples with normozoospermic and asthenozoospermic profiles were
prepared using a direct swim-up technique. Basal concentrations of NO and
stimulated NO production were measured after exposure to the calcium
ionophore (A23187; 0.01-10 microM) a potent activator of constitutive NOS.
NO production in human spermatozoa was significantly increased by the
addition of A23187 30 seconds after stimulation. Furthermore, this response
was greatly diminished by pre-incubating the samples with competitive
inhibitors of L-arginine, the substrate for NOS, before treatment with
calcium ionophore. In the presence of N(G)-nitro-L-arginine methyl ester
(L- NAME), N(G)-nitro-L-arginine (L-NA) or N(G)-methyl-L-arginine (L-NMMA;
all at 10 microM), NO production was inhibited with a rank order of potency
L-NAME > L-NMMA > L-NA which is in accordance with the inhibition of
an endothelial type of constitutive NOS.
相似文献
44.
WT Cade DN Reeds KE Mondy ET Overton J Grassino S Tucker C Bopp E Laciny S Hubert S Lassa‐Claxton KE Yarasheski 《HIV medicine》2010,11(6):379-388
Objective
People living with HIV infection are at increased risk for developing cardiovascular disease (CVD). Safe and effective interventions for lowering CVD risk in HIV infection are high priorities. We conducted a prospective, randomized, controlled study to evaluate whether a yoga lifestyle intervention improves CVD risk factors, virological or immunological status, or quality of life (QOL) in HIV‐infected adults relative to standard of care treatment in a matched control group.Methods
Sixty HIV‐infected adults with mild–moderate CVD risk were assigned to 20 weeks of supervised yoga practice or standard of care treatment. Baseline and week 20 measures were: 2‐h oral glucose tolerance test with insulin monitoring, body composition, fasting serum lipid/lipoprotein profile, resting blood pressures, CD4 T‐cell count and plasma HIV RNA, and the Medical Outcomes Study Short Form (SF)‐36 health‐related QOL inventory.Results
Resting systolic and diastolic blood pressures improved more (P=0.04) in the yoga group (−5 ± 2 and −3 ± 1 mmHg, respectively) than in the standard of care group (+1 ± 2 and+2 ± 2 mmHg, respectively). However, there was no greater reduction in body weight, fat mass or proatherogenic lipids, or improvements in glucose tolerance or overall QOL after yoga. Immune and virological status was not adversely affected.Conclusion
Among traditional lifestyle modifications, yoga is a low‐cost, simple to administer, nonpharmacological, popular behavioural intervention that can lower blood pressure in pre‐hypertensive HIV‐infected adults with mild–moderate CVD risk factors.45.
Background
Polyurethane (PU) foam is widely used as a model for cancellous bone. The higher density foams are used as standard biomechanical test materials, but none of the low density PU foams are universally accepted as models for osteoporotic (OP) bone. The aim of this study was to determine whether low density PU foam might be suitable for mimicking human OP cancellous bone. 相似文献46.
47.
本文报告从海南省十一个HIV监测哨点采集的19653份血清标本中,发现了5例HIV抗体阳性者。这5例都是从泰国探亲回国时检测证实为Ⅰ型艾滋病病毒感染者的,表明我省近期内HIV传播的主要威胁途径为境外感染。 相似文献
48.
Despite a prolonged survival of around 15 years linked to a prolonged complete remission induced by myelosuppression, myeloproliferative syndromes such as polycythemia vera (PV) and essential thrombosis (ET) remain at risk of lethal adverse affects such as thrombotic events and acute transformation. The major risk at diagnosis, in the absence of treatment, is essentially thrombosis. Different therapeutic trials have shown the necessity to maintain circulating blood cells (RBC and platelets counts) near normal levels to avoid thrombosis. Phlebotomies alone in PV lead in the long run to metaplasia and increased platelet counts and should only be kept for emergency cell count reduction. Myelosuppression is thus until recently the most widely accepted effective alternative. However, the effects of long term chronic administration of myelosuppresive agents needs to be analyzed and monitored as the biological changes which appear during the course of these diseases linked or not to the intrinsic clonal haematopoietic abnormality may lead to malignant transformation. Thus, alternative therapies need to be evaluated and predisposition factors taken in account. 相似文献
49.
Peter J. Dyck MD James W. Albers MD James Wolfe Charles F. Bolton MD Nancy Walsh R ET RT Christopher J. Klein MD Andrew J. Zafft R EMG/EP T James W. Russell MD Karen Thomas R EEG/EP T Jenny L. Davies BA Rickey E. Carter PhD L. Joseph Melton III MD William J. Litchy MD the Clinical vs. Neurophysiology Trial Investigators 《Muscle & nerve》2013,48(3):369-374
50.
Lin AY; Kingma DW; Lennette ET; Fears TR; Whitehouse JM; Ambinder RF; Jaffe ES; Levine PH; Tucker MA 《Blood》1996,88(8):3160-3165
Several studies suggest that the Epstein-Barr virus (EBV) is etiologically linked to Hodgkin's disease (HD). This study was undertaken to examine the role of EBV in familial HD (FHD). Among 60 FHD patients from 27 families with two or more cases per family, we tested available paraffinized tumor tissues from 46 cases by in situ hybridization for EBV-encoded RNA (EBER1) expression. Thirteen of 46 FHD patients (28%) had EBER1 expressed in the Reed-Sternberg cells. Concordance rate of EBV positivity was evaluated among 34 first-degree related pairs from 17 families for which both cases had available paraffinized tumor tissues. Only two of 17 pairs were concordant for EBER1 positivity. There was no excess of positive concordance (P = .18). Serologically, FHD patients had higher geometric mean antibody titers (GMTs) to the viral capsid antigen (VCA) and early antigen D (EA- D). There was no difference in seroprevalence between patients and control groups, nor was there concordance in elevated serology among 15 pairs of first-degree related FHD cases. Young adult unaffected family members (UFM) may not react to EBV in the same way as the general population as evidenced by the lower titer of VCA, although not statistically significant, and significantly lower titers of EA-D, compared with age-matched controls. While EBV might have some role in a subset of HD, lack of concordance of EBER1 expression and EBV serology among the FHD cases in the same family suggest that EBV does not play an important role in FHD. 相似文献